Akebia Therapeutics, Inc. (AKBA) by event type
AKBA moves most on coverage initiations — a median of -2.25% at 30 minutes across 12 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the AKBA overview →
How AKBA reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,291 of 2,717 | 16 | -0.40% | 38% | -0.62% |
| Analyst downgrades 2,232 of 2,603 | 18 | -0.52% | 39% | -0.85% |
| Coverage initiations 2,234 of 2,283 | 12 | -2.25% | 42% | -1.01% |
| Rating reiterations 271 of 3,522 | 42 | +0.33% | 55% | +0.39% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how AKBA usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · AKBA overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Albireo Pharma, Inc. (ALBO) | 378 | +0.05% | 53% |
| REPRO MED SYSTEMS INC (REPR) | 378 | 0.00% | 26% |
| Amneal Pharmaceuticals, Inc. - Class A (AMRX) | 377 | -0.08% | 46% |
| Autolus Therapeutics plc - American Depositary Shares (AUTL) | 377 | -0.00% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.